Search Results
Aug 25, 2026, 06:15 ET Innovent Announces 2026 Interim Results and Business Updates
pipeline – including IBI3032 (once‑daily oral GLP‑1), IBI3042 (once‑weekly oral GLP‑1), IBI3040 (Amylin), IBI3046 (INHBE siRNA) and IBI3030 (monthly PCSK9‑GGG) – provides deep, long‑term growth reserves in global obesity and metabolic disease. In cardiovascular & metabolism, autoimmune and ophthalmology,
More news about: Innovent Biologics
Mar 05, 2026, 11:00 ET Francis Medical Announces First Commercial Vanquish® Procedures in Arizona for Prostate Tissue Ablation
adoption."In VAPOR 2 at 6-months, 91% of eligible patients showed elimination of targeted MRI visible, biopsy confirmed intermediate-risk disease (≥GGG2) following a single Vanquish procedure. The procedure was also well-tolerated, with no device-related serious adverse events and low rates of urinary
More news about: Francis Medical, Inc.
Feb 03, 2026, 10:00 ET Francis Medical Announces First Commercial Procedure with the Vanquish® Water Vapor System for Prostate Tissue Ablation
community."Six-month biopsy data on the first 110 patients in the VAPOR 2 study demonstrated elimination of targeted MRI visible, biopsy confirmed, intermediate risk (≥GGG2) disease in 91% of patients following a single Vanquish procedure. There were no device-related serious adverse events and low rates of urinary incontinence
More news about: Francis Medical, Inc.
Dec 02, 2025, 09:30 ET Francis Medical Receives FDA 510(k) Clearance for Use of the Vanquish® Water Vapor System for Prostate Tissue Ablation in Patients with Intermediate Risk Prostate Cancer
localized prostate cancer.Six-month biopsy data on the first 110 patients demonstrated elimination of targeted MRI visible intermediate risk (≥GGG2) disease in 91% of patients following a single Vanquish procedure. There were no device-related serious adverse events and low rates of urinary incontinence
More news about: Francis Medical, Inc.
Sep 23, 2025, 11:36 ET From Investment to Green Card: Golden Gate Global Celebrates another I-829 Approval as an EB-5 Industry Leader
Golden Gate Global (GGG), recognized as one of the top EB-5 regional centers, is proud to announce the first approval of an I-829 petition for an investor in its
More news about: Golden Gate Global
Sep 23, 2025, 11:36 ET From Investment to Green Card: Golden Gate Global Celebrates another I-829 Approval as an EB-5 Industry Leader
Golden Gate Global (GGG), recognized as one of the top EB-5 regional centers, is proud to announce the first approval of an I-829 petition for an investor in its
More news about: Golden Gate Global